AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Drug Design

Showing 121 to 130 of 538 articles

Clear Filters

Extracting medicinal chemistry intuition via preference machine learning.

Nature communications
The lead optimization process in drug discovery campaigns is an arduous endeavour where the input of many medicinal chemists is weighed in order to reach a desired molecular property profile. Building the expertise to successfully drive such projects...

Integrated Molecular Modeling and Machine Learning for Drug Design.

Journal of chemical theory and computation
Modern therapeutic development often involves several stages that are interconnected, and multiple iterations are usually required to bring a new drug to the market. Computational approaches have increasingly become an indispensable part of helping r...

Small-Molecule Conformer Generators: Evaluation of Traditional Methods and AI Models on High-Quality Data Sets.

Journal of chemical information and modeling
Small-molecule conformer generation (SMCG) is an extremely important task in both ligand- and structure-based computer-aided drug design, especially during the hit discovery phase. Recently, a multitude of artificial intelligence (AI) models tailored...

Artificial intelligence for prediction of biological activities and generation of molecular hits using stereochemical information.

Journal of computer-aided molecular design
In this work, we develop a method for generating targeted hit compounds by applying deep reinforcement learning and attention mechanisms to predict binding affinity against a biological target while considering stereochemical information. The novelty...

A pharmacophore-guided deep learning approach for bioactive molecular generation.

Nature communications
The rational design of novel molecules with the desired bioactivity is a critical but challenging task in drug discovery, especially when treating a novel target family or understudied targets. We propose a Pharmacophore-Guided deep learning approach...

Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.

Methods (San Diego, Calif.)
Artificial intelligence (AI), particularly deep learning as a subcategory of AI, provides opportunities to accelerate and improve the process of discovering and developing new drugs. The use of AI in drug discovery is still in its early stages, but i...

Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?

Bioorganic chemistry
Utilizing artificial intelligence (AI) in drug design represents an advanced approach for identifying targets and developing new drugs. Integrating AI techniques significantly reduces the workload involved in drug development and enhances the efficie...

Deep learning driven de novo drug design based on gastric proton pump structures.

Communications biology
Existing drugs often suffer in their effectiveness due to detrimental side effects, low binding affinity or pharmacokinetic problems. This may be overcome by the development of distinct compounds. Here, we exploit the rich structural basis of drug-bo...

Ligand binding affinity prediction with fusion of graph neural networks and 3D structure-based complex graph.

Physical chemistry chemical physics : PCCP
Accurate prediction of protein-ligand binding affinity is pivotal for drug design and discovery. Here, we proposed a novel deep fusion graph neural networks framework named FGNN to learn the protein-ligand interactions from the 3D structures of prote...